29 Mar FINAL EXPLORER Infographic Digital

Posted at 16:11h in by

New Phase 3 Study Finds XARELTO® to Be Superior to Aspirin for Long-Term Prevention of
Recurrent Blood Clots Without Observing any Significant Increase in Major Bleeding in
Patients with Venous Thromboembolism